In glioma, both in vitro and in vivo studies demonstrate that GACAT3 inhibits apoptosis by attenuating miR-3127-5p and consequently elevating ELAVL1 levels (Pan et al., 2019). The gene discussed is ELAVL1; the disease is central nervous system cancer.